PLSCR2
Phospholipid scramblase 2
Also known as: PLS2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRY7
- Gene
- PLSCR2
- Ensembl
- ENSG00000163746
- Chromosome
- 3
- Canonical length
- 297 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm,Endoplasmic reticulum,Vesicles
OverviewNCBI Gene
This gene encodes a member of the phospholipid scramblase family. Phospholipid scramblases are membrane proteins that mediate calcium-dependent, non-specific movement of plasma membrane phospholipids and phosphatidylserine exposure. The encoded protein contains a low affinity calcium binding motif and may play a role in blood coagulation and apoptosis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2011]
Canonical amino-acid sequenceUniProt
297 residues, UniProt reviewed canonical sequence.
>Q9NRY7|PLSCR2
1 MRSWNSLFCL NSSRPPGHIV YPKHQAGHTG KQADHLGSQA FYPGRQHDYL VPPAGTAGIP
61 VQNQPGRPEG VPWMPAPPPP LNCPPGLEYL SQIDMILIHQ QIELLEVLFS FESSNMYEIK
121 NSFGQRIYFA AEDTNFCIRN CCGRSRPFTL RITDNVGREV ITLERPLRCN CCCCPCCLQE
181 IEIQAPPGVP VGYVTQTWHP CLTKFTIKNQ KREDVLKISG PCIVCSCIAG VDFEITSLDE
241 QIVVGRISKH WSGFLREAFT DADNFGIQFP RDLDVKMKAV MIGACFLIDY MFFERTRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLSCR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- testis: 13 nTPM
- epididymis: 1.4 nTPM
- bone marrow: 1.1 nTPM
- fallopian tube: 0.5 nTPM
- gallbladder: 0.5 nTPM
- pancreas: 0.5 nTPM
Single-cell type
- late spermatids: 438 nCPM
- early spermatids: 300 nCPM
- late primary spermatocytes: 121 nCPM
- renal collecting duct principal cells: 43 nCPM
- renal connecting tubule cells: 39 nCPM
- distal convoluted tubule cells: 34 nCPM
Immune cell
- classical monocyte: 0.2 nTPM
- memory CD8 T-cell: 0.2 nTPM
- naive CD4 T-cell: 0.2 nTPM
- naive CD8 T-cell: 0.2 nTPM
- neutrophil: 0.2 nTPM
- NK-cell: 0.2 nTPM
Brain region
- medulla oblongata: 2.5 nTPM
- cerebral cortex: 2.2 nTPM
- hypothalamus: 2.2 nTPM
- pons: 2.1 nTPM
- thalamus: 2.1 nTPM
- spinal cord: 2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLSCR2 as an antibody target. Whether an autoantibody or antibody against PLSCR2 could matter depends on whether native PLSCR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLSCR2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PLSCR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...